Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

On January 21, 2020, OncoSec Medical Incorporated (the "Company") announced that Ms. Sara Bonstein, Chief Financial Officer and Chief Operating Officer of the Company, would be stepping down from her positions in the Company effective January 30, 2020. Ms. Bonstein's decision to resign from the Company was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

On January 21, 2020, the Company also announced that effective January 30, 2020, Mr. Robert J. DelAversano would become the Company's Principal Accounting Officer and Controller.

Robert J. DelAversano, 48, is currently Executive Director of Finance of the Company. Mr. DelAversano has over fifteen years of experience in accounting including thirteen years in public accounting. He will assume the role of Principal Accounting Officer and Controller. Prior to joining the Company, Mr. DelAversano was the Director of Financial Reporting and Taxation at Brio Financial Group ("Brio"), where he served as the firm's Director of Financial Reporting and Taxation, consulting with various public companies in financial reporting, internal control development and evaluation, budgeting and forecasting. Prior to joining Brio, Mr. DelAversano was a manager at Bartolomei Pucciarelli, LLC. Within that capacity, Mr. DelAversano oversaw the Accounting and Tax practice with industry focuses in real estate development and management, manufacturing and wholesalers, construction contractors, and professional services firms and medical devices and services. In addition, he performed audit services, outsourced chief financial officer functions, and/or consulted clients through difficult Securities and Exchange Commission comment periods particularly through application of complex accounting principles for a vast public company client base.

No family relationships exist between Mr. DelAversano and any of our directors or other executive officers. There are no arrangements between Mr. DelAversano and any other person pursuant to which Mr. DelAversano was selected as our controller and principal accounting officer, nor are there any transactions to which the Company is or was a participant and in which Mr. DelAversano has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

A press release regarding the above is furnished hereto as Exhibit 99.1

Item 9.01 Financial Statements and Exhibits.

The following exhibit is furnished as part of this report:





Exhibit
Number    Description

99.1        Press Release dated January 21, 2020.

© Edgar Online, source Glimpses